SCHEMBL6408788

SCHEMBL6408788

NN1CCC2CC=CC=C21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9432506 0.89
SCHEMBL1448244 0.85 KCNH2 (0.32)
SCHEMBL1240961 0.76
SCHEMBL28144960 0.73
SCHEMBL29098232 0.73
SCHEMBL1270009 0.72
SCHEMBL4276737 0.71
SCHEMBL11155231 0.69 SLC18A3 (0.36)
SCHEMBL23047083 0.69
SCHEMBL6114034 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2735567-B1 HETEROCYCLIC SUBSTITUTED PYRIMIDINE COMPOUND XUANZHU PHARMA CO LTD (CN) 2016-10-26 EP disclosed
EP-2735567-A1 HETEROCYCLIC SUBSTITUTED PYRIMIDINE COMPOUND Xuanzhu Pharma Co., Ltd. (CN) 2014-05-28 EP disclosed
US-6855730-B2 3-methylidenyl-2-indolinone modulators of protein kinase SUGEN, INC. (US) 2005-02-15 US disclosed
US-20040024010-A1 3-methylidenyl-2-indolinone modulators of protein kinase SUGEN, INC. 2004-02-05 US disclosed
US-6531502-B1 Antitumor SUGEN, INC. 2003-03-11 US disclosed
WO-2000008202-A9 3-METHYLIDENYL-2-INDOLINONE MODULATORS OF PROTEIN KINASE SUGEN INC (US) 2000-07-27 WO disclosed
WO-2000008202-A2 3-METHYLIDENYL-2-INDOLINONE MODULATORS OF PROTEIN KINASE SUGEN, INC. (US) 2000-02-17 WO disclosed